Updated Jul 16, 2026
Fried Robert N has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Robert N. Fried is the Chief Executive Officer of Niagen Bioscience, Inc. He has been involved in the biotechnology sector, focusing on innovative health solutions. Details about his previous roles and educational background are not widely available.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | NAGE | Niagen Bioscience, Inc. | A — Grant or award | 1.1K | $2.71 | $3K |
| 2026-04-27 | NAGE | Niagen Bioscience, Inc. | M — Option exercise | 20.0K | $2.61 | $52K |
Robert N. Fried is the Chief Executive Officer of Niagen Bioscience, Inc. He has been involved in the biotechnology sector, focusing on innovative health solutions. Details about his previous roles and educational background are not widely available.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Fried Robert N profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.